FORM 38.5(b) - Osmotica Pharmaceuticals plc

FORM 38.5(b) - Osmotica Pharmaceuticals plc

BARCLAYS PLC

Ap27

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

1. KEY INFORMATION

Name of exempt principal trader:	BARCLAYS CAPITAL SECURITIES LTD
Company dealt in	OSMOTICA PHARMACEUTICALS PLC
Class of relevant security to which the	US$0.01 ordinary shares
dealings being disclosed relate
Date of dealing	24 November 2020

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

Class of relevant security:		ORD
		Interests		Short Positions
		Number	(%)	Number	(%)
(1)	Relevant securities owned
		4,291	0.01%	143,893	0.23%
(2)	Derivatives (other than options):
		127,760	0.20%	0	0.00%
(3)	Options and agreements to
	purchase/sell:	0	0.00%	0	0.00%
	TOTAL:	132,051	0.21%	143,893	0.23%

b. Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 2)

Class of relevant security:	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap28

3. DEALINGS (Note 3)

a. Purchases and sales

Class of relevant	Purchase/sale	Number of	Price per unit
security		securities
US$0.01 ordinary shares	Purchase	88	5.7900 USD

b. Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 5)	Number of relevant securities (Note 6)	Price per unit (Note 4)

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasingor varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 4)

ii. Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 4)

d. Other dealings (including transactions in respect of new securities) (Note 3)

Nature of transaction (Note 7)	Details	Price per unit (if applicable) (Note 4)

Ap29

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 38.5(b) attached?	NO
Date of disclosure:	25 Nov 2020
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
Name of offeree/offeror with which connected
Nature of connection

View source version on businesswire.com: https://www.businesswire.com/news/home/20201125005561/en/